argenx SE (ARGX) stock

ARGXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 19, 2026Score 5/30

$981.33+3.75 (+0.38%)

Close on Nov 12, 2026Market cap –P/E 50.1Yield –

argenx ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

argenx has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?